TickerFacts.

A business in context

AMRX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-01 · 0001628280-26-060179

  2. 4 · Ownership change

    Report date 2026-08-21 · 0001628280-26-058918

  3. 4 · Ownership change

    Report date 2026-08-13 · 0001628280-26-057147

  4. 4 · Ownership change

    Report date 2026-08-12 · 0001628280-26-056757

  5. 4 · Ownership change

    Report date 2026-08-11 · 0001628280-26-056754

  6. 4 · Ownership change

    Report date 2026-08-11 · 0001628280-26-056752

  7. 4 · Ownership change

    Report date 2026-08-10 · 0001628280-26-056297

  8. 4 · Ownership change

    Report date 2026-08-10 · 0001628280-26-056288

  9. 8-K · Current report

    Report date 2026-08-10 · 0001140361-26-032014 · Items 1.01,2.01,2.03,3.02,7.01,9.01

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001723128-26-000031

  11. 8-K · Current report

    Report date 2026-08-03 · 0001628280-26-051900 · Items 1.01

  12. 8-K · Current report

    Report date 2026-07-31 · 0001140361-26-030491 · Items 5.07

  13. 8-K · Current report

    Report date 2026-07-30 · 0001723128-26-000025 · Items 2.02,7.01,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001723128-26-000020

  15. 8-K · Current report

    Report date 2026-05-07 · 0001723128-26-000019 · Items 2.02,9.01

  16. 8-K · Current report

    Report date 2026-05-06 · 0001628280-26-032137 · Items 5.07

  17. 8-K · Current report

    Report date 2026-04-22 · 0001193125-26-168231 · Items 1.01,2.02,3.02,7.01,9.01

  18. DEF 14A · Proxy statement

    Report date 2026-05-06 · 0001308179-26-000143

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001723128-26-000011

  20. 8-K · Current report

    Report date 2026-02-27 · 0001723128-26-000008 · Items 2.02,7.01,9.01

  21. 8-K · Current report

    Report date 2026-02-02 · 0001628280-26-004738 · Items 1.01,2.03

  22. 8-K · Current report

    Report date 2026-01-23 · 0001628280-26-003842 · Items 8.01

  23. 8-K · Current report

    Report date 2026-01-13 · 0001723128-26-000003 · Items 2.02,7.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001723128-25-000062

  25. 8-K · Current report

    Report date 2025-10-30 · 0001723128-25-000059 · Items 2.02,7.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001723128-25-000047

  27. 8-K/A · Current report

    Report date 2025-08-05 · 0001723128-25-000040 · Items 5.07

  28. 8-K · Current report

    Report date 2025-08-05 · 0001723128-25-000037 · Items 2.02,7.01,9.01

  29. 8-K · Current report

    Report date 2025-08-01 · 0000950103-25-009701 · Items 1.01,2.03,9.01

  30. 8-K · Current report

    Report date 2025-07-24 · 0000950103-25-009253 · Items 8.01,9.01

  31. 8-K · Current report

    Report date 2025-07-16 · 0001723128-25-000033 · Items 2.02,5.02,7.01,9.01

  32. 8-K · Current report

    Report date 2025-07-21 · 0000950103-25-009025 · Items 8.01,9.01

  33. 8-K · Current report

    Report date 2025-05-08 · 0001723128-25-000024 · Items 5.07

  34. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001723128-25-000022

  35. 8-K · Current report

    Report date 2025-05-02 · 0001723128-25-000018 · Items 2.02,7.01,9.01

  36. DEF 14A · Proxy statement

    Report date 2025-05-06 · 0001308179-25-000220

  37. 8-K · Current report

    Report date 2025-03-01 · 0001723128-25-000014 · Items 5.02

  38. 10-K · Annual report

    Report date 2024-12-31 · 0001723128-25-000012

  39. 8-K · Current report

    Report date 2025-02-28 · 0001723128-25-000009 · Items 2.02,7.01,9.01

  40. 8-K · Current report

    Report date 2025-01-15 · 0001723128-25-000005 · Items 2.02,7.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 8 transaction rows8AExercise / conversion: 16 transaction rows16MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

25 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-11
2026-05-12
Autor Deborah M.S · Sale
Disposed
Class A Common Stock34819.012.94
2026-05-07
2026-05-08
BUCHI J KEVINM · Exercise / conversion
Acquired
Class A Common Stock34819.0—
2026-05-07
2026-05-08
BUCHI J KEVINM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
34819.00.0
2026-05-07
2026-05-08
Autor Deborah M.M · Exercise / conversion
Acquired
Class A Common Stock34819.0—
2026-05-07
2026-05-08
Autor Deborah M.M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
34819.00.0
2026-05-07
2026-05-08
George Jeffrey P.M · Exercise / conversion
Acquired
Class A Common Stock34819.0—
2026-05-07
2026-05-08
George Jeffrey P.M · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
34819.00.0
2026-05-07
2026-05-08
Patel GautamM · Exercise / conversion
Acquired
Class A Common Stock34819.0—
2026-05-07
2026-05-08
Patel GautamM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
34819.00.0
2026-05-07
2026-05-08
Kiely JohnM · Exercise / conversion
Acquired
Class A Common Stock34819.0—
2026-05-07
2026-05-08
Kiely JohnM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
34819.00.0
2026-05-07
2026-05-08
Nark Ted CM · Exercise / conversion
Acquired
Class A Common Stock34819.0—
2026-05-07
2026-05-08
Nark Ted CM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
34819.00.0
2026-05-07
2026-05-08
MEISTER PAUL MM · Exercise / conversion
Acquired
Class A Common Stock48747.0—
2026-05-07
2026-05-08
MEISTER PAUL MM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
48747.00.0
2026-05-07
2026-05-08
Yanai ShlomoM · Exercise / conversion
Acquired
Class A Common Stock34819.0—
2026-05-07
2026-05-08
Yanai ShlomoM · Exercise / conversion
Disposed
Restricted Stock Units
Derivative security
34819.00.0
2026-05-06
2026-05-08
BUCHI J KEVINA · Grant / award
Acquired
Restricted Stock Units
Derivative security
19824.00.0
2026-05-06
2026-05-08
Autor Deborah M.A · Grant / award
Acquired
Restricted Stock Units
Derivative security
19824.00.0
2026-05-06
2026-05-08
George Jeffrey P.A · Grant / award
Acquired
Restricted Stock Units
Derivative security
19824.00.0
2026-05-06
2026-05-08
Patel GautamA · Grant / award
Acquired
Restricted Stock Units
Derivative security
19824.00.0
2026-05-06
2026-05-08
Kiely JohnA · Grant / award
Acquired
Restricted Stock Units
Derivative security
19824.00.0
2026-05-06
2026-05-08
Nark Ted CA · Grant / award
Acquired
Restricted Stock Units
Derivative security
19824.00.0
2026-05-06
2026-05-08
MEISTER PAUL MA · Grant / award
Acquired
Restricted Stock Units
Derivative security
30837.00.0
2026-05-06
2026-05-08
Yanai ShlomoA · Grant / award
Acquired
Restricted Stock Units
Derivative security
19824.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001723128Amneal Pharmaceuticals, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300VV176ZO5WQHZ61
GLEIF legal name
AMNEAL PHARMACEUTICALS, INC.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2023-08-04T17:28:28Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Impax Laboratories · alias · wikidata
  • Atlas Holdings, Inc. · former SEC name · 2017-11-21 to 2018-04-13
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$2.79B$2.97B
2023-12-31$2.39B$2.62B
2022-12-31$2.21B$2.52B
2021-12-31$2.09B$2.58B
2020-12-31$1.99B$2.57B
2019-12-31$1.63B$2.12B
2018-12-31$1.66B$2.21B
2017-12-31$1.03B$1.41B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗